ABBV-706

• UNSPSC Description:

  ABBV-706 is a SEZ6 targeting ADC, which is composed of the Linker-Payload conjugation (HY-148820) and the Anti-SEZ6 Antibody (SC17) (HY-P991041). ABBV-706 exhibits high efficacy against small cell lung cancer (SCLC), neuroendocrine tumors (NENs) and central nervous system (CNS) tumors[1].

• Target Antigen:

  Antibody-Drug Conjugates (ADCs)

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/abbv-706.html

• Smiles:

  [ABBV-706]

• References & Citations:

  [1]Chandana S R, et al. First-in-human study of ABBV-706, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors[J]. 2024.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported